UnitedHealth Board Member Expands Stake: Now Holds Over 4,700 Shares Across Trusts

Rhea-AI Filing Summary

UnitedHealth Group director Paul R. Garcia reported insider trading activity on June 24, 2025. The transaction involved the acquisition of 11 shares of Common Stock as dividend equivalents paid on vested deferred stock units, received at $0 price.

Following the transaction, Garcia's beneficial ownership consists of:

• 2,481 shares held directly
• 2,146 shares held indirectly through a Revocable Trust
• 45 shares held indirectly through Trust 2
• 55 shares held indirectly through Trust 3

The dividend equivalents were immediately vested and are subject to the same terms as the underlying deferred stock units. The Form 4 was filed by attorney-in-fact Faraz A. Choudhry on June 26, 2025.

Insider Trade Summary

Net Buyer: 11 shares

Net Buy 4 txns

Insider GARCIA PAUL R

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11	$0.00	$0.00
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 2,481 shares (Direct); Common Stock — 2,146 shares (Indirect, By Revocable Trust); Common Stock — 45 shares (Indirect, By Trust 2); Common Stock — 55 shares (Indirect, By Trust 3)

Footnotes (1)

1. F1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 06/26/2025 - 04:23 PM Learn about SEC filing dates

FAQ

What insider transaction occurred at UNH on June 24, 2025?

Director Paul R. Garcia acquired 11 shares of UNH common stock at $0 per share through dividend equivalents paid on vested deferred stock units. These dividend equivalents vested immediately and are subject to the same terms as the underlying deferred stock units.

How many UNH shares does Director Paul Garcia own directly after this transaction?

Following the reported transaction, Paul Garcia directly owns 2,481 shares of UNH common stock.

What is the total indirect ownership of UNH shares by Paul Garcia?

Paul Garcia indirectly owns a total of 2,246 shares of UNH through various trusts: 2,146 shares in a Revocable Trust, 45 shares in Trust 2, and 55 shares in Trust 3.

Who filed this Form 4 for UNH and when was it filed?

The Form 4 was filed by Faraz A. Choudhry, serving as Attorney-in-Fact for Paul R. Garcia, on June 26, 2025.

What type of insider transaction triggered this UNH Form 4 filing?

The Form 4 was triggered by the acquisition of dividend equivalents on vested deferred stock units, which resulted in the immediate vesting of 11 additional shares at $0 cost basis.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GARCIA PAUL R

(Last) (First) (Middle)

C/O UNITEDHEALTH GROUP INCORPORATED

1 HEALTH DRIVE

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/24/2025		A		11(1)	A	$0	2,481	D
Common Stock								2,146	I	By Revocable Trust
Common Stock								45	I	By Trust 2
Common Stock								55	I	By Trust 3

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Remarks:

	Faraz A. Choudhry, Attorney-in-Fact for Paul R. Garcia	06/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.